MYOPRIDIN Tablet Ref.[10974] Active ingredients: Pridinol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Mibe pharma UK Ltd, 4 Coleman Street, 6th Floor, London, EC2R 5AR, United Kingdom

4.1. Therapeutic indications

Central and peripheral muscle spasms: lumbar pain, torticollis, general muscle pain, in adults.

4.2. Posology and method of administration

Posology

The recommended dose is 1.5-3 mg pridinol 3 times daily

The duration of administration is decided by the treating doctor.

Administration is independent of meals, with the onset of the effect being faster when the medicinal product is taken before meals.

Patients who suffer from hypotension should take the tablets after meals to reduce the risk of fainting.

Children and adolescents

No data are available

Method of administration

For oral use.

The tablets should be taken with sufficient fluid (e.g. 1 glass of water) and not chewed.

4.9. Overdose

In the event of overdose or accidental poisoning, symptoms that are typical for anticholinergics occur.

When the severity of the symptoms requires it, intravenous physostigmine salicylate should be administered slowly.

6.3. Shelf life

5 years.

6.4. Special precautions for storage

Do not store above 25°C.

6.5. Nature and contents of container

PVC//Al blisters.

Packs with 20, 50 and 100 tablets.

Hospital packs with 200 (10 × 20), 500 (10 × 50) and 1000 (10 × 100) tablets

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.